Risk Factors for COVID-19 Mortality
NCT04786808 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2021-11-15
Summary
COVID-19 pandemic has deeply burdened hospitals all over the world. A two-stage disease has been hypothesized due to quick worsening of clinical status after 7-10 days from the beginning of first symptoms, generally flu-like symptoms. Predicting clinical worsening could help to address major efforts towards higher risk patients.
During the last year most observational studies, generally retrospective, has been conducted, identifying some risk factors such as age, obesity, male gender, cardiovascular disease, COPD, diabetes etc.
The study goal is to collect systematically a variegate amount of clinical, biometric, laboratory and radiological data from patients admitted to the Emergency Medicine Ward of Piacenza Hospital (Italy), in order to prospectively analyze what characteristics are associated to higher risk of mortality.
Conditions
- COVID-19 Virus Infection
- Population at Risk
- Acute Respiratory Distress Syndrome
Sponsors & Collaborators
-
Teodoro Marcianò
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-15
- Primary Completion
- 2021-11-07
- Completion
- 2021-11-07
Countries
- Italy
Study Locations
More Related Trials
-
Risk Factors and Prognoses in Patients Hospitalized for COVID-19
NCT04824677 ·Status: COMPLETED
-
Independent Predictors on Clinical Outcomes in SARS-CoV2 Patients
NCT05162534 ·Status: COMPLETED
-
Prospective Evaluation of the Predictive Criteria of Severity for Respiratory Infection Due to COVID-19 Virus
NCT04615676 ·Status: COMPLETED
-
Covid-19 Associated Coagulopathy Predicted by Thrombodynamic Markers (CoViTro-I)
NCT05330832 ·Status: UNKNOWN
-
Risk Factors Worsening COVID19 for Out-patient With Home Monitoring
NCT04380662 ·Status: UNKNOWN
-
Predictors of COVID-19 Infection and Disease Progression
NCT04484597 ·Status: UNKNOWN
-
Comorbidities and Risk Score in COVID-19 Patients
NCT04670094 ·Status: COMPLETED
-
International SARS-CoV-2 (COVID-19) Infection Observational Study
NCT04385251 ·Status: COMPLETED
-
Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino)
NCT04361916 ·Status: TERMINATED ·Phase: NA
-
Long-term Pulmonary Outcomes After Infection With Sars-CoV-2
NCT04401163 ·Status: COMPLETED
-
Nasal and Pulmonary Nitric Oxide Output in COVID-19 Infection
NCT04728919 ·Status: UNKNOWN
-
Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia
NCT04332913 ·Status: UNKNOWN
-
COVID-19 Epidemic Response Study
NCT04357496 ·Status: WITHDRAWN
-
Infectious Pathogens in Acute Respiratory Illness in Adults and Elderly
NCT01360398 ·Status: COMPLETED ·Phase: NA
-
Early Identification and Severity Prediction of Acute Respiratory Infectious Disease
NCT04955756 ·Status: UNKNOWN ·Phase: NA
-
Predictive Immune Biomarkers for COVID-19 Pathogenesis
NCT04385108 ·Status: COMPLETED ·Phase: NA
-
Clinical Characteristics And Outcome Of COVID-19 Infection In Patients With Chronic Respiratory Diseases.
NCT05054127 ·Status: UNKNOWN
-
Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19
NCT04581135 ·Status: COMPLETED
-
Multiparametric Assessment of Peripheral Blood and Tissue Myeloid Cells. Phenotype for Precision Medicine in Patients With SARS-Cov-2 Infection
NCT05767853 ·Status: UNKNOWN
-
Mechanisms for Covid-19 Disease Complications
NCT04314232 ·Status: UNKNOWN
-
Lymphocyte to Procalcitonin Ratio in Covid-19 Patients
NCT06620159 ·Status: ACTIVE_NOT_RECRUITING
-
Predictive Immune Biomarkers of COVID-19 Pathogenesis to Influence Therapeutic Management
NCT04668170 ·Status: COMPLETED
-
Validation of Prognostic Clinical Risk Scores in Predicting Outcome for Patients With COVID-19 at Initial Triage
NCT05582382 ·Status: UNKNOWN
-
A Study to Investigate Acute Respiratory Virus Infections in Participants at High Risk for Severe Illness
NCT05661604 ·Status: COMPLETED
-
Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung Infection by Covid-19.
NCT06601998 ·Status: RECRUITING